Press release
Key Factor Supporting Mantle Cell Lymphoma Therapeutics Market Development in 2025: The Surge In Mantle Cell Lymphoma Prevalence Driving Growth In Therapeutics Market
Mantle Cell Lymphoma Therapeutics
How Large Will the Mantle Cell Lymphoma Therapeutics Market Size By 2025?
The market size of therapeutics for mantle cell lymphoma has seen a steady uptick in the past few years. It is anticipated to enhance from $2.42 billion in 2024 to $2.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.2%. The growth during the historical period can be connected to advancements in research, successful clinical trials, upgraded diagnostic tools, broadened access to treatment, and collective research endeavors.
How Big Is the Mantle Cell Lymphoma Therapeutics Market Size Expected to Grow by 2029?
Strong expansion in the mantle cell lymphoma therapeutics market is anticipated in the coming years; it is predicted to increase to "$3.56 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.0%. The predicted surge during the forecast period is due to the advancement in targeted treatments, emergence of innovative immunotherapies, the rise in personalized medicine, worldwide market growth, and escalating incidence rates. Key trends in the forecast period encompass advancements in immunotherapy, precision medicine innovation, biomarker growth, targeted therapies aimed at specific pathways, combination therapies, and the adoption of artificial intelligence (AI).
View the full report here:
https://www.thebusinessresearchcompany.com/report/mantle-cell-lymphoma-therapeutics-global-market-report
Which Key Market Drivers Powering Mantle Cell Lymphoma Therapeutics Market Expansion and Growth?
The increasing occurrence of mantle cell lymphoma is anticipated to boost the expansion of the market for mantle cell lymphoma therapeutics in the future. Mantle cell lymphoma (MCL) is a variant of non-Hodgkin lymphoma (NHL), a cancer that impacts the lymphatic system. Therapeutics for Mantle Cell Lymphoma assists in limiting the disease's frequency by providing treatment and management for the condition while enhancing patient outcomes, extending survival rates, and diminishing the disease's impact. For example, in December 2022, the National Library of Medicine, a biomedical library overseen by the United States Federal Government, reported that the yearly incidence of mantle cell lymphoma is one in a percentage of 200,000 individuals, making up 5% of all non-Hodgkins lymphomas. Therefore, the escalating prevalence of mantle cell lymphoma is fuelling the development of the mantle cell lymphoma therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10813&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Mantle Cell Lymphoma Therapeutics Market?
Targeted drug development is a significant trend in the mantle cell lymphoma therapeutics market. In March 2023, UK-based AstraZeneca secured approval from China's NMPA for Calquence (acalabrutinib), a selective BTK inhibitor intended to offer an effective and well-tolerated therapy for adult patients with mantle cell lymphoma.
What Are the Emerging Segments in the Mantle Cell Lymphoma Therapeutics Market?
The mantle cell lymphoma therapeutics market covered in this report is segmented -
1) By Type: Combination Therapy, Monotherapy
2) By Mechanism of Action: Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms
3) By Route of Administration: Oral, Parenteral
4) By Application: Hospital, Research Institute, Other Applications
Subsegments:
1) By Combination Therapy: Chemotherapy Combinations, Targeted Therapy Combinations, Immunotherapy Combinations
2) By Monotherapy: Single-Agent Chemotherapy, Targeted Therapy Monotherapy, Immunotherapy Monotherapy
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10813&type=smp
Who Are the Global Leaders in the Mantle Cell Lymphoma Therapeutics Market?
Major companies operating in the mantle cell lymphoma therapeutics market include AstraZeneca plc, Celgene Corporation, Johnson & Johnson Consumer Inc., Takeda Pharmaceutical Company Limited, Bayer Aktiengesellschaft, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Kite Pharma Inc., Gilead Sciences Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Merck & Co. Inc., Massive Bio Inc., Juno Therapeutics Inc., Nurix Therapeutics Inc., Janssen Biotech Inc., TG Therapeutics Inc., F. Hoffmann-La Roche AG, Astex Pharmaceuticals Inc., Astellas Pharma Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Exelixis Inc., Hutchison China MediTech Limited, Incyte Corporation, Ionis Pharmaceuticals Inc.
Which are the Top Profitable Regional Markets for the Mantle Cell Lymphoma Therapeutics Industry?
North America was the largest region in the global mantle cell lymphoma therapeutics market in 2024. The regions covered in the mantle cell lymphoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10813
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Factor Supporting Mantle Cell Lymphoma Therapeutics Market Development in 2025: The Surge In Mantle Cell Lymphoma Prevalence Driving Growth In Therapeutics Market here
News-ID: 4095022 • Views: …
More Releases from The Business Research Company
Surge of Sustainability And Natural Ingredients In The Cruelty-Free Makeup Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Cruelty-Free Makeup Market Size By 2025?
The market size for cruelty-free cosmetics has experienced substantial growth in the last few years. It is anticipated to escalate from $6.35 billion in 2024 to $6.85 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.9%.…
Emerging Trends to Drive Positive Material Identification Market Growth at 7.6% …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Positive Material Identification Market Size Growth Forecast: What to Expect by 2025?
The market size for positive material identification has experienced significant expansion in recent years. The market value which was $3.07 billion in 2024 is projected to increase to $3.26 billion in 2025, with a compound annual growth…
Rising Emergency Call Volumes Fuels The Growth Of The Computer Aided Dispatch Ma …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Computer Aided Dispatch Market Through 2025?
In recent times, there has been a quick expansion in the size of the computer aided dispatch market. Its growth is projected to accelerate from $2.09 billion in 2024 to $2.33 billion in 2025, exhibiting a…
Key Trends Reshaping the Nucleic Acid Isolation & Purification Market: Innovativ …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Nucleic Acid Isolation & Purification Market Size Growth Forecast: What to Expect by 2025?
The market size of nucleic acid isolation and purification has witnessed a robust expansion in recent periods. The market is projected to escalate from a worth of $6.03 billion in 2024 to around $6.6 billion…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
